GATX vs GSK · P/E 19, rev $1.16B vs P/E 13, $103.31B cap
GATX Corporation (GATX) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
GATX Corporation (GATX) is a rental & leasing services company listed on NYSE.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported GATX revenue for 2026-06-30 was $1.16B. Net income was $188.9M. Revenue was up 99.4% from 2026-03-31 to 2026-06-30. GATX currently screens at market cap $6.23B and trailing P/E 18.8.
GSK does not have a complete income-statement cache yet.
GATX currently screens at market cap $6.23B and trailing P/E 18.8. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the GATX and GSK stock pages for the full models.
Not investment advice.